Alterations of NMDA receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats

Alterations of NMDA receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats
复制标题

6-羟基多巴胺诱导的帕金森病大鼠各脑区 NMDA 受体结合的变化

DOI:
10.3109/00207454.2013.853058
复制
发表时间:
2014-06
影响因子:
2.2
通讯作者:
Huang, Xufeng
Huang, Xufeng
中科院分区:
医学4区
文献类型:
--
作者:
Qin, Bing;Xie, Junqiang;Deng, Chao;Huang, Xufeng

文献摘要

参考文献

相似文献

The N-methyl-d-aspartate (NMDA) system closely interacts with the dopaminergic system and is strongly implicated in the pathophysiological mechanisms and therapeutic paradigms of Parkinson's disease. This study aims to systematically investigate the changes of NMDA receptors in a wide range of brain structures 3 weeks after unilateral medial forebrain bundle lesion by 6-hydroxydopamine (6-OHDA). NMDA receptor distributions and alterations in the post-mortem rat brain were detected by [3H] MK-801 binding autoradiography. In the 6-OHDA-induced Parkinsonian rat model, nigrostriatal dopaminergic neuron loss significantly mediated the decreased [3H] MK-801 binding, predominantly in the hippocampus (−22.4%, p < 0.001), caudate putamen (−14.1%, p < 0.01), accumbens nucleus (−13.8%, p < 0.05), cingulate cortex (−13.4%, p < 0.001), posteromedial cortical amygdala (−14.5%, p < 0.01) and piriform cortex (−9%, p < 0.05) compared to the controls, while there was a profound reduction of tyrosine hydroxylase (TH) immunohistochemistry in the substantia nigra pars compacta. Alterations in [3H] MK-801 in the specific brain regions related to cognitive functions may indicate that cognitive dysfunctions caused by 6-OHDA lesion were via the NMDA system. The downregulation of NMDA receptor binding in the present study provides indirect evidence for plasticity in the NMDA system in the rat brain. The present study improves our understanding of the critical roles of the NMDA receptors in treating neurodegenerative disorders, and implicates NMDA receptors as a novel therapeutic target in the treatment of Parkinson's disease.
阿尔茨海默病和帕金森病的神经递质受体和认知功能障碍
DOI: 10.1016/j.pneurobio.2012.02.002
发表时间: 2012-04
影响因子: 6.7
作者:
Xu, Yunqi;Yan, Junqiang;Zhou, Peng;Li, Jiejie;Gao, Huimin;Xia, Ying;Wang, Qing
通讯作者: Wang, Qing
DOI: 10.1016/j.expneurol.2008.01.016
发表时间: 2008-05-01
影响因子: 5.3
作者:
Adams, Michelle M.;Shi, Lei;Brunso-Bechtold, Judy K.
通讯作者: Brunso-Bechtold, Judy K.
DOI: 10.1371/journal.pone.0020945
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者:
Yan J;Xu Y;Zhu C;Zhang L;Wu A;Yang Y;Xiong Z;Deng C;Huang XF;Yenari MA;Yang YG;Ying W;Wang Q
通讯作者: Wang Q
DOI: 10.1523/jneurosci.0792-06.2006
发表时间: 2006-04-26
影响因子: 5.3
作者:
Hallett, PJ;Spoelgen, R;Dunah, AW
通讯作者: Dunah, AW
亚麻木酚素对 NMDA 诱导神经毒性的体外神经保护作用
DOI: 10.1111/cns.12003
发表时间: 2012-01-01
影响因子: 5.5
作者:
Li, Xu-Bo;Yang, Zhao-Xu;Zhao, Ming-Gao
通讯作者: Zhao, Ming-Gao